Dongliang Li

Development of a novel anoikis-related prognostic signature and validation of CD36 as a potential target for reversing 5-FU resistance in gastric cancer

Gastric cancer (GC) remains a leading cause of cancer-related mortality, with chemoresistance and metastasis being primary hurdles to effective treatment. Anoikis resistance is a critical survival mechanism enabling tumor dissemination; however, the cellular heterogeneity of anoi...